Clinical Trials Logo

Shock, Septic clinical trials

View clinical trials related to Shock, Septic.

Filter by:

NCT ID: NCT00592488 Completed - Septic Shock Clinical Trials

Acetyl-L-Carnitine in the Treatment of Septic Shock

ALC
Start date: August 2006
Phase: Phase 1/Phase 2
Study type: Interventional

This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic shock requiring vasopressors.

NCT ID: NCT00534287 Completed - Septic Shock Clinical Trials

Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock

MaxSep
Start date: October 2007
Phase: Phase 3
Study type: Interventional

Severe sepsis and septic shock are diseases of infectious origin with a high risk of death. Antibiotic therapy is mandatory but it is unknown whether one antibiotic alone is sufficient for initial therapy. The purpose of this study is to compare a therapy with meropenem alone or the combination of meropenem plus moxifloxacin in the treatment of severe sepsis/ septic shock. Patients randomly receive one of the two treatments for at least 7 days but not longer than 14 days.

NCT ID: NCT00527007 Completed - Septic Shock Clinical Trials

External Cooling in Septic Shock Patients

sepsis-cool
Start date: October 2007
Phase: N/A
Study type: Interventional

The rapidity of the resolution of cardiovascular failure has a strong impact on septic shock patients' outcome. The aim of this multicenter randomized controlled trial is to determine whether external cooling might accelerate improvement in cardiovascular function.

NCT ID: NCT00523198 Completed - Septic Shock Clinical Trials

Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic Shock

Start date: February 2007
Phase: N/A
Study type: Observational

The purpose of the study is: - to correlate salivary cortisol to free serum cortisol (as salivary cortisol is considered to be almost complete free cortisol) and, - to correlate free serum cortisol to total serum cortisol levels Both in patients with septic shock (severe sepsis requiring vasopressors). We believe that: - total serum cortisol does not correlate with free serum cortisol in patient with septic shock and, - that salivary cortisol correlates with free serum cortisol and can be used to determine the level of free serum cortisol.

NCT ID: NCT00481572 Completed - Septic Shock Clinical Trials

Continuous Infusion of Terlipressin in Septic Shock

Start date: January 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether: A)the continuous infusion ultra-low dose of terlipressin (1.3 micrograms/kg/h) is able to stabilize hemodynamic in patients with septic shock, reducing the risk of adverse effects related to the bolus dose.B)the continuous infusion ultra-low dose of terlipressin may be use in lieu of vasopressin.

NCT ID: NCT00481442 Completed - Septic Shock Clinical Trials

Phenylephrine Versus Norepinephrine in Septic Shock

Start date: January 2007
Phase: Phase 2
Study type: Interventional

Clinical studies evaluating the clinical use of phenylephrine in septic shock are lacking. The present study was designed to compare the effects of norepinephrine and phenylephrine on systemic and regional hemodynamics in patients with catecholamine-dependent septic shock.

NCT ID: NCT00407823 Completed - Septic Shock Clinical Trials

Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation Monitoring

Start date: January 2004
Phase: N/A
Study type: Interventional

The purpose of this study was to compare ACCM/PALS guidelines performed with and without central venous oxygen saturation monitoring on the morbidity and mortality rate of children with severe sepsis and septic shock.

NCT ID: NCT00406198 Completed - Sepsis Clinical Trials

Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis

Start date: March 1997
Phase: Phase 4
Study type: Interventional

The impact of continuous veno-venous haemofiltration (CVVH) on sepsis-induced multiple organ failure severity is controversial. We thus sought to assess the effect of early application of haemofiltration on the degree of organ dysfunction and plasma cytokine levels in patients with severe sepsis or septic shock.

NCT ID: NCT00398736 Completed - Septic Shock Clinical Trials

A Non-invasive Approach to the Assessment of Volume Status in Mechanically Ventilated Septic Patients.

Start date: n/a
Phase: Phase 2
Study type: Observational

To evaluate the use of sonographic inferior caval vein assessment in mechanically ventilated septic patients. Volume assessment in mechanically ventilated patients with inflammation is of major importance to guide fluid therapy. The researchers investigated whether measurement of caval vein diameter correlates with invasively assessed volume-based hemodynamic parameters.

NCT ID: NCT00329680 Completed - Sepsis Clinical Trials

The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis

Start date: June 2007
Phase: Phase 4
Study type: Interventional

The scope of this clinical study is to evaluate the possible role of an enteral formulation enriched with EPA, GLA and Antioxidants in patients diagnosed in the early stages of sepsis despite mechanical ventilation requirements, as well as the impact of this diet upon glycemic control and its capacity to prevent the development of sepsis into severe sepsis and septic shock.